MYCN and neuroblastoma: However, Ham et al. demonstrated that N-Myc amplified neuroblastomas were sensitive to the Bcl-2 inhibitor ABT-199 and could be further sensitized to ABT-199 with the Aurora Kinase A inhibitor MLN8237, which results in a downregulation of Mcl-1 [13].